{"id":11246,"date":"2025-07-27T04:27:15","date_gmt":"2025-07-27T02:27:15","guid":{"rendered":"https:\/\/valintermed.com\/?p=11246"},"modified":"2025-07-27T04:27:15","modified_gmt":"2025-07-27T02:27:15","slug":"sindrom-fg","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/sindrom-fg\/","title":{"rendered":"FG syndrome"},"content":{"rendered":"
<\/div>\n

FH syndrome (phenylhydrazine type) is a rare genetic disorder associated with a disorder of amino acid metabolism, namely phenylalanine. This disorder leads to its accumulation in the body, which can cause serious consequences for the development of the nervous system and the general functional activity of a person. Damage to the central nervous system, impairment of cognitive functions and mental status are all characteristics of FH syndrome. Its manifestations can vary from mild mental retardation to pronounced neurological symptoms. Diagnosis of the disease is often carried out at an early stage of life, but it is not always possible to recognize it at an early stage, which, in turn, can complicate the early initiation of the necessary therapy.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n